Gene · 3872
Papers3,832
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,832
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pachyonychia Congenita with a Novel Variant in the KRT16 Gene, c.348_379delinsAA. | Ann Dermatol | 2022 | 36478435 | PubTator, text mining | PubMed |
| Editorial: Cancer systems biology. | Front Genet | 2022 | 36468040 | PubTator, text mining | PubMed |
| Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. | Front Pharmacol | 2022 | 36467074 | PubTator, text mining | PubMed |
| A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer. | Front Oncol | 2022 | 36465388 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type. | Aging Dis | 2022 | 36465169 | PubTator, text mining | PubMed |
| Exaggerated Placental Site as a Cause of Hysterectomy for Massive Bleeding After First Trimester Voluntary Abortion. | J Obstet Gynaecol India | 2022 | 36458070 | PubTator, text mining | PubMed |
| Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis. | Sci Rep | 2022 | 36450789 | PubTator, text mining | PubMed |
| Oral Lichen Planus and Oral Squamous Cell Carcinoma share key oncogenic signatures. | Sci Rep | 2022 | 36450755 | PubTator, text mining | PubMed |
| Immunohistochemical Study of p16INK4A, MIB-1 and CK17 in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix. | Gulf J Oncolog | 2022 | 36448068 | PubTator, text mining | PubMed |
| Application of second-generation sequencing in congenital pulmonary airway malformations. | Sci Rep | 2022 | 36443638 | PubTator, text mining | PubMed |
| SOTIP is a versatile method for microenvironment modeling with spatial omics data. | Nat Commun | 2022 | 36443314 | PubTator, text mining | PubMed |
| LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437914 | PubTator, text mining | PubMed |
| Targeted NGS in Diagnostics of Genodermatosis Characterized by the Epidermolysis Bullosa Symptom Complex in 268 Russian Children. | Int J Mol Sci | 2022 | 36430820 | PubTator, text mining | PubMed |
| Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma. | Int J Mol Sci | 2022 | 36430324 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability. | Cancers (Basel) | 2022 | 36428672 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma. | Front Oncol | 2022 | 36419893 | PubTator, text mining | PubMed |
| TBX1 targets the miR-200-ZEB2 axis to induce epithelial differentiation and inhibit stem cell properties. | Sci Rep | 2022 | 36418889 | PubTator, text mining | PubMed |
| Functional and clinical characteristics of focal adhesion kinases in cancer progression. | Front Cell Dev Biol | 2022 | 36407100 | PubTator, text mining | PubMed |
| Cervical cancer heterogeneity: a constant battle against viruses and drugs. | Biomark Res | 2022 | 36397138 | PubTator, text mining | PubMed |
| Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer. | Front Cell Dev Biol | 2022 | 36393868 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3872/papers?page=36